Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection

Int Ophthalmol. 2009 Oct;29(5):411-3. doi: 10.1007/s10792-008-9237-z. Epub 2008 Jun 5.

Abstract

Purpose: To report a case of culture-positive endophthalmitis after intravitreal injection of bevacizumab (Avastin) resulting in a devastating visual outcome.

Method: A retrospective case report of a 51-year-old diabetic women who presented with further decrease in her vision, redness, and mild pain in her eye 3 days after intravitreal injection of Avastin for macular edema due to a branch retinal vein occlusion.

Results: Clinical diagnosis of endophthalmitis was made and, after obtaining a vitreous tap, intravitreal antibiotics were administered. Because of worsening of the endophthalmitis, pars plana vitrectomy was undertaken followed by repeat intravitreal antibiotics injection. The patient's ocular condition improved dramatically; however, her visual acuity did not improve. The cultures from vitreous taps revealed Staphylococcus lugdunesis.

Conclusion: Intravitreal injection of Avastin may be associated with a risk of S. lugdunesis-caused endophthalmitis which can have a devastating effect on the final visual outcome.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Anti-Bacterial Agents / administration & dosage
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Drug Therapy, Combination
  • Endophthalmitis / microbiology*
  • Endophthalmitis / pathology
  • Endophthalmitis / physiopathology
  • Endophthalmitis / therapy
  • Female
  • Humans
  • Injections, Intraocular / adverse effects*
  • Lens, Crystalline / surgery
  • Macular Edema / drug therapy
  • Macular Edema / etiology
  • Middle Aged
  • Retinal Vein Occlusion / complications
  • Retrospective Studies
  • Staphylococcal Infections / etiology*
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity
  • Vitrectomy / methods
  • Vitreous Body

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab